Comparison of Vestibular Stimulation and Core Stability Training on Sitting Balance in Hypotonic CP

November 2, 2026 updated by: Riphah International University

Comparison of Vestibular Stimulation and Core Stability Training on Sitting Balance in Hypotonic Cerebral Palsy

To compare the effectiveness of core stability training and vestibular stimulation on sitting balance in hypotonic Cerebral Palsy

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
    • Punjab Province
      • Chakwal, Punjab Province, Pakistan
        • Recruiting
        • Helping Hand for Relief and Development
        • Contact:
        • Principal Investigator:
          • Zahra Jahan, MS-PPT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 8 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 2-8 years.

    • Clinical diagnosis of hypotonic cerebral palsy.
    • Segmental assessment of trunk control - not full independent trunk control.
    • Cognitive ability (who follows command)
    • Medical stability

Exclusion Criteria:

Progressive neurological disorder.

  • Uncontrolled epilepsy.
  • Visual or hearing impairment
  • Behavioral problems
  • Vertigo

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Core stability and conventional

Core stability training and conventional therapy on sitting balance in Hypotonic cerebral palsy
Other: Core stability training with conventional therapy

Basic core stability training with supine bridging, lateral weight shifting and conventional therapy with trunk facilitation. Sessions will be conducted 5 time per week for 8 weeks. Sessions lasts for 30 minutes.
Active Comparator: Vestibular stimulation and conventional therapy

Vestibular stimulation and conventional therapy on sitting balance in hypotonic cerebral palsy
Other: Vestibular Stimulation with conventional therapy

Vestibular stimulation with gym ball and swing along with conventional therapy. Sessions will be conducted 5 time per week for 8 weeks. Sessions lasts for 30 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Segmental assessment of trunk control
Time Frame: week 0 , week 4, week 8

To evaluate trunk stability and it has 7 levels. Each level consists of 3 components(static, active and reactive). Trunk stability will be measured baseline (0 week), mid intervention(4 weeks) and post intervention(8 weeks).
week 0 , week 4, week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pediatric Balance Scale
Time Frame: week 0 , week 4, week 8

To assess static and dynamic balance. It consists of 14 items scoring from (0=unable, 1=maximal assistance , 2= moderate assistance , 3=minimal assistance). Total score is 56.Static and dynamic balance will be measured baseline (0 week), mid intervention(4 weeks) and post intervention(8 weeks).
week 0 , week 4, week 8
Pediatric Evaluation of Disability inventory
Time Frame: week 0 , week 4, week 8

To assess functional mobility and daily activities. it consists of 3 domains scoring from (0= child does not perform activity , 1 = child perform activity). Total functional score is 12. Functional mobility will be measured baseline (0 week), mid intervention(4 weeks) and post intervention(8 weeks).
week 0 , week 4, week 8
Reaching Performance Scale
Time Frame: week 0 , week 4, week 8

To assess quality of reaching movements. It has 6 components scoring from(0=no performance , 1= poor performance, 2= moderate performance, 3= good performance) Total score is 18.Quality of reaching movement will be measured baseline (0 week), mid intervention(4 weeks) and post intervention(8 weeks).
week 0 , week 4, week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Qamar Mehmood, MS, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

November 2, 2026

First Submitted That Met QC Criteria

November 2, 2026

First Posted (Actual)

November 6, 2026

Study Record Updates

Last Update Posted (Actual)

November 6, 2026

Last Update Submitted That Met QC Criteria

November 2, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/MS-PT/02473 Zahra Jahan

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe